-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
PerkinElmer, Inc. (NYSE:PKI) Shares Sold by Bank of America Corp DE
PerkinElmer, Inc. (NYSE:PKI) Shares Sold by Bank of America Corp DE
Bank of America Corp DE reduced its stake in shares of PerkinElmer, Inc. (NYSE:PKI – Get Rating) by 1.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 621,750 shares of the medical research company's stock after selling 8,833 shares during the quarter. Bank of America Corp DE owned 0.49% of PerkinElmer worth $108,470,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in PKI. Allworth Financial LP grew its position in PerkinElmer by 14,100.0% during the first quarter. Allworth Financial LP now owns 284 shares of the medical research company's stock worth $50,000 after buying an additional 282 shares during the period. Covestor Ltd grew its position in PerkinElmer by 25.1% during the first quarter. Covestor Ltd now owns 359 shares of the medical research company's stock worth $63,000 after buying an additional 72 shares during the period. MV Capital Management Inc. grew its position in PerkinElmer by 1,085.1% during the first quarter. MV Capital Management Inc. now owns 557 shares of the medical research company's stock worth $97,000 after buying an additional 510 shares during the period. Ellevest Inc. grew its position in PerkinElmer by 35.3% during the first quarter. Ellevest Inc. now owns 716 shares of the medical research company's stock worth $125,000 after buying an additional 187 shares during the period. Finally, Harvest Fund Management Co. Ltd grew its position in shares of PerkinElmer by 128.4% in the first quarter. Harvest Fund Management Co. Ltd now owns 765 shares of the medical research company's stock valued at $133,000 after purchasing an additional 430 shares during the last quarter. 77.06% of the stock is currently owned by institutional investors and hedge funds.
Get PerkinElmer alerts:Analyst Upgrades and Downgrades
Several analysts have recently commented on PKI shares. The Goldman Sachs Group lowered their price target on shares of PerkinElmer from $200.00 to $175.00 and set a "neutral" rating on the stock in a research report on Thursday, July 14th. Barclays lowered their price target on shares of PerkinElmer from $149.00 to $140.00 and set an "underweight" rating on the stock in a research report on Monday, September 12th. Bank of America lowered shares of PerkinElmer from a "buy" rating to a "neutral" rating and set a $178.00 price target on the stock. in a research report on Tuesday, August 2nd. UBS Group started coverage on shares of PerkinElmer in a research report on Wednesday, July 20th. They issued a "buy" rating and a $160.00 price target on the stock. Finally, Stifel Nicolaus lowered shares of PerkinElmer from a "buy" rating to a "hold" rating and lowered their price target for the company from $190.00 to $170.00 in a research report on Thursday, August 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $162.50.
Insiders Place Their Bets
In other PerkinElmer news, insider Andrew Okun sold 3,173 shares of the stock in a transaction that occurred on Monday, August 1st. The shares were sold at an average price of $165.42, for a total transaction of $524,877.66. Following the transaction, the insider now owns 6,391 shares of the company's stock, valued at $1,057,199.22. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, insider Daniel R. Tereau sold 5,700 shares of the firm's stock in a transaction on Friday, July 22nd. The shares were sold at an average price of $145.14, for a total transaction of $827,298.00. Following the completion of the sale, the insider now directly owns 13,380 shares of the company's stock, valued at approximately $1,941,973.20. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Andrew Okun sold 3,173 shares of the firm's stock in a transaction on Monday, August 1st. The shares were sold at an average price of $165.42, for a total transaction of $524,877.66. Following the sale, the insider now directly owns 6,391 shares of the company's stock, valued at $1,057,199.22. The disclosure for this sale can be found here. 0.52% of the stock is currently owned by insiders.PerkinElmer Stock Performance
Shares of PKI opened at $122.31 on Friday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.42 and a current ratio of 2.02. The company has a market capitalization of $15.44 billion, a price-to-earnings ratio of 22.90, a PEG ratio of 0.35 and a beta of 1.14. PerkinElmer, Inc. has a 1 year low of $120.12 and a 1 year high of $203.16. The company's 50 day simple moving average is $142.81 and its 200 day simple moving average is $150.09.
PerkinElmer (NYSE:PKI – Get Rating) last posted its quarterly earnings results on Monday, August 1st. The medical research company reported $2.32 earnings per share for the quarter, topping analysts' consensus estimates of $2.03 by $0.29. The company had revenue of $1.23 billion for the quarter, compared to the consensus estimate of $1.20 billion. PerkinElmer had a net margin of 13.21% and a return on equity of 16.68%. PerkinElmer's revenue was up .1% on a year-over-year basis. During the same quarter last year, the firm posted $2.83 earnings per share. On average, sell-side analysts predict that PerkinElmer, Inc. will post 7.83 EPS for the current year.
PerkinElmer Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, November 11th. Shareholders of record on Friday, October 21st will be paid a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.23%. The ex-dividend date is Thursday, October 20th. PerkinElmer's dividend payout ratio is currently 5.24%.
About PerkinElmer
(Get Rating)
PerkinElmer, Inc provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services.
Further Reading
- Get a free copy of the StockNews.com research report on PerkinElmer (PKI)
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- 2 Semiconductor Stocks To Watch For Reversals
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.
根據美國銀行提交給美國證券交易委員會的最新Form 13F檔案,美國銀行DE在第一季度減持了PerkinElmer,Inc.(紐約證券交易所代碼:PKI-GET評級)的股票1.4%。該公司在本季度出售了8833股後,持有這家醫學研究公司621,750股股票。截至最近提交給美國證券交易委員會(Securities And Exchange Commission)的檔案,美國銀行DE擁有PerkinElmer 0.49%的股份,價值108,47萬美元。
其他幾家機構投資者和對沖基金最近也增持或減持了他們在PKI的股份。Allworth Financial LP在第一季度將其在PerkinElmer的頭寸增加了14,100.0%。Allworth Financial LP現在擁有284股這家醫療研究公司的股票,價值5萬美元,在此期間又購買了282股。Covestor Ltd在第一季度將其在PerkinElmer的頭寸增加了25.1%。Covestor Ltd現在擁有這家醫療研究公司359股股票,價值6.3萬美元,在此期間又購買了72股。MV Capital Management Inc.在第一季度將其在PerkinElmer的頭寸增加了1085.1%。MV Capital Management Inc.現在持有這家醫學研究公司557股股票,價值97,000美元,在此期間又購買了510股。Ellevest Inc.在第一季度將其在PerkinElmer的頭寸增加了35.3%。Ellevest Inc.現在持有這家醫學研究公司716股股票,價值12.5萬美元,在此期間又購買了187股。最後,嘉實基金管理有限公司在第一季度增持了128.4%的PerkinElmer股票。嘉實基金管理有限公司在上個季度增持了430股後,現在持有這家醫學研究公司765股股票,價值13.3萬美元。77.06%的股票目前由機構投資者和對沖基金持有。
到達PerkinElmer警報:分析師升級和下調評級
幾位分析師最近對PKI股票發表了評論。7月14日,高盛夫婦在一份研究報告中將PerkinElmer的股票目標價從200.00美元下調至175.00美元,並將該股的評級定為“中性”。巴克萊將PerkinElmer的股票目標價從149.00美元下調至140.00美元,並在9月12日(星期一)的一份研究報告中將該股的評級定為“減持”。美國銀行將PerkinElmer的股票評級從買入下調至中性,並為該股設定了178.00美元的目標價。在8月2日星期二的一份研究報告中。瑞銀集團在7月20日星期三的一份研究報告中開始對PerkinElmer的股票進行報道。他們對該股給予了“買入”評級和160.00美元的目標價。最後,Stifel Nicolaus在8月18日週四的一份研究報告中將PerkinElmer的股票評級從買入下調至持有,並將該公司的目標價從190.00美元下調至170.00美元。一名分析師對該股的評級為賣出,五名分析師對該公司股票的評級為持有,四名分析師對該公司股票的評級為買入。根據MarketBeat.com的數據,該股目前的共識評級為持有,共識目標價為162.50美元。
內部人士下注
在PerkinElmer的其他新聞中,內部人士Andrew Okun在8月1日星期一的一筆交易中出售了3173股PerkinElmer股票。這些股票以165.42美元的平均價格出售,總成交金額為524,877.66美元。交易完成後,這位內部人士現在擁有該公司6,391股股票,價值1,057,199.22美元。這筆交易是在提交給美國證券交易委員會的一份法律檔案中披露的,該檔案可通過美國證券交易委員會網站。在相關新聞中,內部人士Daniel·R·特羅在7月22日星期五的一次交易中出售了5,700股該公司的股票。這些股票以145.14美元的平均價格出售,總成交金額為827,298.00美元。出售完成後,這位內部人士現在直接持有該公司13,380股股票,價值約1,941,973.20美元。這筆交易是在提交給美國證券交易委員會的一份檔案中披露的,該檔案可通過美國證券交易委員會網站。此外,內部人士安德魯·奧肯在8月1日星期一的一次交易中出售了3173股該公司的股票。這些股票以165.42美元的平均價格出售,總成交金額為524,877.66美元。出售後,這位內部人士現在直接持有該公司6,391股股票,價值1,057,199.22美元。關於這次銷售的披露可以找到這裡。該股目前由內部人士持有0.52%。PerkinElmer股票表現
上週五,PKI的股價開盤報122.31美元。該公司的負債權益比率為0.63,速動比率為1.42,流動比率為2.02。該公司市值為154.4億美元,本益比為22.90倍,聚乙二醇率為0.35倍,貝塔係數為1.14。PerkinElmer,Inc.的一年低點為120.12美元,一年高位為203.16美元。該公司的50日簡單移動均線切入位在142.81美元,200日簡單移動均線切入位在150.09美元。
PerkinElmer(紐約證券交易所代碼:PKI-GET Rating)最近一次公佈季度收益是在8月1日星期一。這家醫療研究公司公佈本季度每股收益為2.32美元,比分析師普遍預期的2.03美元高出0.29美元。該公司本季度營收為12.3億美元,而市場普遍預期為12.億美元。PerkinElmer的淨利潤率為13.21%,股本回報率為16.68%。PerkinElmer的收入同比增長了1.1%。去年同一季度,該公司公佈的每股收益為2.83美元。賣方分析師平均預測,PerkinElmer,Inc.本年度每股收益將達到7.83歐元。
PerkinElmer宣佈派息
該公司最近還宣佈了季度股息,將於11月11日(星期五)支付。10月21日(星期五)登記在冊的股東將獲得每股0.07美元的股息。這意味著年化股息為0.28美元,收益率為0.23%。除息日期為10月20日星期四。PerkinElmer的派息比率目前為5.24%。
關於PerkinElmer
(獲取評級)
PerkinElmer,Inc.為全球診斷、生命科學和應用服務市場提供產品、服務和解決方案。它通過兩個部門運行:發現和分析解決方案以及診斷。發現與分析解決方案部門提供一整套解決方案,包括試劑、資訊學、檢測和成像技術,使科學家能夠加強生命科學研究市場的研究突破,以及合同研究和實驗室服務。
進一步閱讀
- 免費獲取StockNews.com關於PerkinElmer的研究報告(PKI)
- MarketBeat:回顧一週9/19-9/23
- 為什麼特斯拉的股票保持彈性?
- 需要關注的2只半導體類股走勢逆轉
- CrowdStrike是否會從增加每股收益指引中獲得提振?
- 小盤股的裁員是樓市的晴雨錶嗎?
接受PerkinElmer Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對PerkinElmer和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧